PRO-DEX, INC.

PDEX ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $1.6M $5.1M $822.0K $-365.0K $-488.0K $-1.8M $-876.0K $2.6M
Depreciation & Amortization $557.0K $555.0K $614.0K $578.0K $527.0K $582.0K $647.0K $697.0K
Depreciation $522.0K $505.0K $486.0K $534.0K
Amortization $20.0K $20.0K $117.0K $44.0K
Stock-Based Compensation $194.0K $3.0K $4.0K $17.0K $50.0K $100.0K $108.0K $43.0K
Net Cash from Operating Activities $3.1M $3.2M $466.0K $-775.0K $-329.0K $-1.3M $45.0K $2.9M
Investing Activities
Capital Expenditures $923.0K $606.0K $311.0K $244.0K $50.0K $86.0K $341.0K $265.0K
Business Acquisitions $866.0K
Net Cash from Investing Activities $-4.1M $-1.0M $1.6M $323.0K $-452.0K $-259.0K $-265.0K
Financing Activities
Dividends Paid
Stock Repurchases $220.0K $312.0K $454.0K $154.0K $6.0K
Net Cash from Financing Activities $2.0M $-298.0K $-457.0K $1.5M $-709.0K $-363.0K $-1.7M
Net Change in Cash $983.0K $1.9M $1.6M $-2.5M $1.5M $-2.4M $-577.0K $895.0K
Free Cash Flow $2.2M $2.6M $155.0K $-1.0M $-379.0K $-1.4M $-296.0K $2.6M
← Newer Page 2 of 2 Older →